/Stocks
S&P 500NasdaqBiological Products, (No Diagnostic Substances)

Amgen Inc. AMGN

Price

Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)

Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.

Results from SEC filings

Revenue$36.8B+10%FY ending Dec 31, 2025
Operating income$9.1B+25%FY ending Dec 31, 2025
Net income$7.7B+89%FY ending Dec 31, 2025
Earnings per share$14.23+88%FY ending Dec 31, 2025
Research & development$7.3B+22%FY ending Dec 31, 2025
Cash from operations$10.0B-13%FY ending Dec 31, 2025
Capital spending$1.9B+70%FY ending Dec 31, 2025
Share buybacks$0-100%FY ending Dec 31, 2025
Dividends paid$5.1B+6%FY ending Dec 31, 2025
Cash$9.1B-24%FY ending Dec 31, 2025
Long-term debt$50.0B-12%FY ending Dec 31, 2025
Shareholders' equity$8.7B+47%FY ending Dec 31, 2025
Shares outstanding539M+0%FY ending Dec 31, 2025

Insider trades

Last 12 months: 0 open-market buys ($0) and 10 sales ($29.3M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).

InsiderTradeSharesPriceValueDate
Rachna KhoslaSVP, Business DevelopmentSold1,252$416.43$521KAug 13, 2026
Rachna KhoslaSVP, Business DevelopmentSold2,000$412.57$825KAug 11, 2026
Derek MillerSVP, Human ResourcesSold2 fills3,890$402.54 avg$1.6MAug 6, 2026
Nancy A. GrygielSVP & CCOSold2 fills2,970$402.16 avg$1.2MAug 6, 2026
Nancy A. GrygielSVP & CCOSold1,237$323.73$400KMay 4, 2026
Esteban SantosEVP, OperationsSold2 fills54,792$379.12 avg$20.8MFeb 26, 2026
Matthew C. BuschVP, Finance & CAOSold1,000$375.79$376KFeb 19, 2026
Nancy A. GrygielSVP & CCOSold2 fills3,139$337.26 avg$1.1MNov 20, 2025
Murdo GordonEVP, Global Commercial OpsSold6,879$336.83$2.3MNov 12, 2025
Rachna KhoslaSVP, Business DevelopmentSold890$336.24$299KNov 12, 2025
Other insider moves (96): pay awards, option exercises, tax withholding, gifts
InsiderTradeSharesPriceValueDate
Rachna KhoslaSVP, Business DevelopmentOption exercise1,252$162.60$204KAug 13, 2026
Matthew C. BuschVP, Finance & CAOAward730––Aug 7, 2026
Omar IshrakDirectorAward85––Aug 7, 2026
Charles M HolleyDirectorAward103––Aug 7, 2026
Michael V DrakeDirectorAward64––Aug 7, 2026
Derek MillerSVP, Human ResourcesOption exercise2 fills3,890$169.56 avg$660KAug 6, 2026
Nancy A. GrygielSVP & CCOOption exercise2 fills2,970$177.41 avg$527KAug 6, 2026
Amy E MilesDirectorAward665––May 19, 2026
Ellen Jamison KullmanDirectorAward665––May 19, 2026
Mary E. KlotmanDirectorAward665––May 19, 2026
Tyler JacksDirectorAward665––May 19, 2026
Omar IshrakDirectorAward665––May 19, 2026
Charles M HolleyDirectorAward665––May 19, 2026
Greg C. GarlandDirectorAward665––May 19, 2026
Robert EckertDirectorAward665––May 19, 2026
Brian DrukerDirectorAward665––May 19, 2026
Michael V DrakeDirectorAward665––May 19, 2026
Wanda M AustinDirectorAward665––May 19, 2026
Robert A BradwayChairman, CEO and President, DirectorTax withholding2,079$331.11$688KMay 7, 2026
Murdo GordonEVP, Global Commercial OpsTax withholding615$331.11$204KMay 7, 2026
David M ReeseEVP & Chief Technology OfficerTax withholding556$331.11$184KMay 7, 2026
Peter H. GriffithEVP & CFOTax withholding556$331.11$184KMay 7, 2026
Esteban SantosEVP, OperationsTax withholding522$331.11$173KMay 7, 2026
Jonathan P GrahamEVP & Gen. Counsel & Sec.Tax withholding499$331.11$165KMay 7, 2026
James E. BradnerEVP, Research and DevelopmentTax withholding446$331.11$148KMay 7, 2026
Derek MillerSVP, Human ResourcesTax withholding151$331.11$50KMay 7, 2026
Rachna KhoslaSVP, Business DevelopmentTax withholding93$331.11$31KMay 7, 2026
Nancy A. GrygielSVP & CCOTax withholding88$331.11$29KMay 7, 2026
Matthew C. BuschVP, Finance & CAOTax withholding41$331.11$14KMay 7, 2026
Robert A BradwayChairman, CEO and President, DirectorTax withholding1,702$329.59$561KMay 6, 2026
Murdo GordonEVP, Global Commercial OpsTax withholding502$329.59$165KMay 6, 2026
Peter H. GriffithEVP & CFOTax withholding502$329.59$165KMay 6, 2026
David M ReeseEVP & Chief Technology OfficerTax withholding454$329.59$150KMay 6, 2026
Esteban SantosEVP, OperationsTax withholding427$329.59$141KMay 6, 2026
Jonathan P GrahamEVP & Gen. Counsel & Sec.Tax withholding408$329.59$134KMay 6, 2026
James E. BradnerEVP, Research and DevelopmentTax withholding407$329.59$134KMay 6, 2026
Derek MillerSVP, Human ResourcesTax withholding123$329.59$41KMay 6, 2026
Rachna KhoslaSVP, Business DevelopmentTax withholding79$329.59$26KMay 6, 2026
Nancy A. GrygielSVP & CCOTax withholding76$329.59$25KMay 6, 2026
Matthew C. BuschVP, Finance & CAOTax withholding50$329.59$16KMay 6, 2026
James E. BradnerEVP, Research and DevelopmentAward3,337––May 5, 2026
Robert A BradwayChairman, CEO and President, DirectorAward12,136––May 5, 2026
Matthew C. BuschVP, Finance & CAOAward455––May 5, 2026
Murdo GordonEVP, Global Commercial OpsAward3,640––May 5, 2026
Jonathan P GrahamEVP & Gen. Counsel & Sec.Award2,609––May 5, 2026
Peter H. GriffithEVP & CFOAward3,640––May 5, 2026
Nancy A. GrygielSVP & CCOAward485––May 5, 2026
Rachna KhoslaSVP, Business DevelopmentAward500––May 5, 2026
Derek MillerSVP, Human ResourcesAward910––May 5, 2026
David M ReeseEVP & Chief Technology OfficerAward2,912––May 5, 2026
Esteban SantosEVP, OperationsAward2,730––May 5, 2026
Omar IshrakDirectorAward106––May 5, 2026
Charles M HolleyDirectorAward129––May 5, 2026
Michael V DrakeDirectorAward80––May 5, 2026
Robert A BradwayChairman, CEO and President, DirectorTax withholding2 fills5,057$329.82 avg$1.7MMay 2, 2026
Murdo GordonEVP, Global Commercial OpsTax withholding2 fills1,593$329.82 avg$525KMay 2, 2026
David M ReeseEVP & Chief Technology OfficerTax withholding2 fills1,433$329.82 avg$473KMay 2, 2026
Peter H. GriffithEVP & CFOTax withholding2 fills1,433$329.82 avg$473KMay 2, 2026
Esteban SantosEVP, OperationsTax withholding2 fills1,338$329.82 avg$441KMay 2, 2026
Jonathan P GrahamEVP & Gen. Counsel & Sec.Tax withholding2 fills1,257$329.82 avg$415KMay 2, 2026

Trades by members of Congress

13 members reported 17 buys and 13 sales since Aug 7, 2024. Amounts are legal ranges, not exact figures.

MemberTradeAmountTradedReportedOwner
David J. Taylor RBought$1,001–$15KSep 22, 2026Oct 1, 2026Self
David J. Taylor RSold$1,001–$15KAug 26, 2026Sep 5, 2026Self
David J. Taylor RSold$1,001–$15KAug 26, 2026Sep 5, 2026Self
David J. Taylor RBought$1,001–$15KJun 5, 2026Jun 12, 2026Self
Maria Elvira Salazar RSold$15K–$50KApr 17, 2026May 8, 2026Self
Maria Elvira Salazar RBought$15K–$50KMar 24, 2026Apr 21, 2026Self
David J. Taylor RSold$1,001–$15KFeb 26, 2026Mar 6, 2026Self
David J. Taylor RSold$1,001–$15KJan 29, 2026Feb 2, 2026Self
David J. Taylor RBought$1,001–$15KJan 16, 2026Feb 2, 2026Self
Julia Letlow RSold$1,001–$15KNov 19, 2024Jan 13, 2026420 days laterSelf
Julia Letlow RBought$1,001–$15KOct 23, 2024Jan 13, 2026447 days laterSelf
David J. Taylor RSold$1,001–$15KDec 3, 2025Dec 5, 2025Self
David J. Taylor RSold$1,001–$15KDec 3, 2025Dec 5, 2025Self
Marjorie Taylor Greene RBought$1,001–$15KOct 24, 2025Oct 28, 2025Self
Lisa C. McClain RSold$1,001–$15KSep 25, 2025Oct 22, 2025Spouse
Marjorie Taylor Greene RBought$1,001–$15KSep 11, 2025Sep 27, 2025Self
Daniel Meuser RSold$1,001–$15KFeb 11, 2025Aug 20, 2025190 days laterSpouse
Lisa C. McClain RBought$1,001–$15KJun 24, 2025Aug 13, 202550 days laterSpouse
Cliff Bentz RBought$1,001–$15KJun 6, 2025Jul 9, 2025Spouse
Scott Franklin RBought$1,001–$15KAug 7, 2024Jul 3, 2025330 days laterSpouse
Jefferson Shreve RSold$15K–$50KMay 12, 2025Jun 22, 2025Self
Marjorie Taylor Greene RBought$1,001–$15KMay 14, 2025May 19, 2025Self
Jared Moskowitz DBought$1,001–$15KApr 16, 2025May 9, 2025Child
Jared Moskowitz DBought$1,001–$15KApr 16, 2025May 9, 2025Self
Jefferson Shreve RBought$15K–$50KApr 11, 2025May 8, 2025Self
Robert P. Bresnahan, Jr. RSold$1,001–$15KApr 8, 2025May 8, 2025Self
Marjorie Taylor Greene RBought$1,001–$15KMay 5, 2025May 6, 2025Self
Jefferson Shreve RBought$15K–$50KFeb 24, 2025Mar 9, 2025Self
Emily Randall DSold$1,001–$15KJan 6, 2025Feb 11, 2025Spouse
Virginia Foxx RBought$1,001–$15KDec 6, 2024Jan 6, 2025Self

Latest SEC filings

All filings on SEC EDGAR ↗

About Amgen Inc.

Business description
Industry
Biological Products, (No Diagnostic Substances)
Sector
Life Sciences
Headquarters
Thousand Oaks, CA
Incorporated in
DE
Fiscal year ends
December 31
Exchange
Nasdaq
Filer size
Large accelerated filer
SEC company number (CIK)
318154

Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.